| Eric Matthew Karlin, MD | |
|
1144 Professional Dr, Williamsburg, VA 23185-3330 | |
| (757) 259-0443 | |
| (757) 259-0450 |
| Full Name | Eric Matthew Karlin |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 15 Years |
| Location | 1144 Professional Dr, Williamsburg, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356579486 | NPI | - | NPPES |
| 1356579486 | Medicaid | VA | |
| VVK273A | Other | VA | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 0101259719 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Riverside Regional Medical Center | Newport news, VA | Hospital |
| Bon Secours Maryview Medical Center | Portsmouth, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allergy Partners Pllc | 7113822420 | 149 |
News Archive
Cleveland Medical Devices Inc. (CMDI) has announced the formation of Great Lakes NeuroTech (www.GLNeuroTech.com), a spin-off company which has acquired the rights to develop, market, and manufacture clinical motor assessment and therapy systems for the movement disorders market as well as physiological monitors for research and education markets. Great Lakes NeuroTech (GLN) will perform R&D, engineering, manufacturing, distribution, and exporting of these technologies through two divisions: Movement Disorders and Research & Education Systems.
Nventa Biopharmaceuticals Corporation has announced that the U.S. Patent and Trademark Office has issued Patent Number 7,262,014 to Nventa covering compositions and methods for inducing or enhancing immune responses to a human papillomavirus (HPV) antigen with or without the use of an adjuvant.
Athletes who have attention deficit hyperactivity disorder may be at greater risk for experiencing persistent anxiety and depression after a concussion than people who do not have ADHD, according to a preliminary study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Indianapolis, July 20 to 22, 2018. ADHD is a brain disorder that affects attention and behavior.
As the number of deaths related to the pandemic H1N1 virus, commonly known as "swine flu," continues to rise, researchers have been scrambling to decipher its inner workings and explain why the incidence is lower than expected in older adults.
AstraZeneca today announced the availability of DUTOPROL (metoprolol succinate extended release/hydrochlorothiazide) Tablets, the first and only once-daily antihypertensive agent that contains the active ingredient of TOPROL-XL (metoprolol succinate) plus a low-dose diuretic that provides proven blood pressure lowering at 24 hours.
› Verified 1 days ago
| Entity Name | Allergy Partners Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740416247 PECOS PAC ID: 7113822420 Enrollment ID: O20091030000066 |
News Archive
Cleveland Medical Devices Inc. (CMDI) has announced the formation of Great Lakes NeuroTech (www.GLNeuroTech.com), a spin-off company which has acquired the rights to develop, market, and manufacture clinical motor assessment and therapy systems for the movement disorders market as well as physiological monitors for research and education markets. Great Lakes NeuroTech (GLN) will perform R&D, engineering, manufacturing, distribution, and exporting of these technologies through two divisions: Movement Disorders and Research & Education Systems.
Nventa Biopharmaceuticals Corporation has announced that the U.S. Patent and Trademark Office has issued Patent Number 7,262,014 to Nventa covering compositions and methods for inducing or enhancing immune responses to a human papillomavirus (HPV) antigen with or without the use of an adjuvant.
Athletes who have attention deficit hyperactivity disorder may be at greater risk for experiencing persistent anxiety and depression after a concussion than people who do not have ADHD, according to a preliminary study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Indianapolis, July 20 to 22, 2018. ADHD is a brain disorder that affects attention and behavior.
As the number of deaths related to the pandemic H1N1 virus, commonly known as "swine flu," continues to rise, researchers have been scrambling to decipher its inner workings and explain why the incidence is lower than expected in older adults.
AstraZeneca today announced the availability of DUTOPROL (metoprolol succinate extended release/hydrochlorothiazide) Tablets, the first and only once-daily antihypertensive agent that contains the active ingredient of TOPROL-XL (metoprolol succinate) plus a low-dose diuretic that provides proven blood pressure lowering at 24 hours.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eric Matthew Karlin, MD Po Box 603725, Charlotte, NC 28260-3725 Ph: (828) 575-2625 | Eric Matthew Karlin, MD 1144 Professional Dr, Williamsburg, VA 23185-3330 Ph: (757) 259-0443 |
News Archive
Cleveland Medical Devices Inc. (CMDI) has announced the formation of Great Lakes NeuroTech (www.GLNeuroTech.com), a spin-off company which has acquired the rights to develop, market, and manufacture clinical motor assessment and therapy systems for the movement disorders market as well as physiological monitors for research and education markets. Great Lakes NeuroTech (GLN) will perform R&D, engineering, manufacturing, distribution, and exporting of these technologies through two divisions: Movement Disorders and Research & Education Systems.
Nventa Biopharmaceuticals Corporation has announced that the U.S. Patent and Trademark Office has issued Patent Number 7,262,014 to Nventa covering compositions and methods for inducing or enhancing immune responses to a human papillomavirus (HPV) antigen with or without the use of an adjuvant.
Athletes who have attention deficit hyperactivity disorder may be at greater risk for experiencing persistent anxiety and depression after a concussion than people who do not have ADHD, according to a preliminary study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Indianapolis, July 20 to 22, 2018. ADHD is a brain disorder that affects attention and behavior.
As the number of deaths related to the pandemic H1N1 virus, commonly known as "swine flu," continues to rise, researchers have been scrambling to decipher its inner workings and explain why the incidence is lower than expected in older adults.
AstraZeneca today announced the availability of DUTOPROL (metoprolol succinate extended release/hydrochlorothiazide) Tablets, the first and only once-daily antihypertensive agent that contains the active ingredient of TOPROL-XL (metoprolol succinate) plus a low-dose diuretic that provides proven blood pressure lowering at 24 hours.
› Verified 1 days ago
Dr. Stephen Wyatt Shield, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1144 Professional Dr, Williamsburg, VA 23185 Phone: 757-259-0443 Fax: 757-259-0450 | |
Thomas Andrew Makin, MD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 1144 Professional Dr, Williamsburg, VA 23185 Phone: 757-259-0443 Fax: 757-259-0450 | |
Joan L Brauckmann, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 1144 Professional Dr, Williamsburg, VA 23185 Phone: 757-259-0443 Fax: 757-259-0450 | |
Dr. Timothy John Campbell, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1144 Professional Dr, Williamsburg, VA 23185 Phone: 757-259-0443 Fax: 757-259-0450 |